tykhr
sign in
free sign up
Anavex Life Sciences Corp
Biotechnology
Healthcare
AVXL
84.54 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
7.45
52 week high
13.46
high
8.72
52 week low
3.70
low
7.27
growth
114.78 %
previous Close
7.60
P/E ratio
market cap
948 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
17.65 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top